Want to take quizzes and track your credits? Sign Up
In this randomized trial, there was no difference in ICU-acquired bloodstream infections caused by multidrug-resistant gram-negative bacteria (MDRGNB) among ventilated ICU patients given chlorhexidine 2% mouthwash, selective oropharyngeal decontamination (mouthpaste with colistin, tobramycin, and nystatin), or selective digestive tract decontamination (the same mouthpaste and gastrointestinal suspension with the same antibiotics), all applied 4 times daily. Bastiaan H. Wittekamp, MD, PhD, of University Medical Center Utrecht, the Netherlands, presents findings from the R-GNOSIS ICU trial at the European Society of Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
or
You currently have no searches saved.
You currently have no courses saved.